The viral protein, called AcrVA2, is the only known anti-CRISPR that sabotages CRISPR this way. “When we first put AcrVA2 into bacterial cells with Cas12, we saw Cas12 disappear,” said Joseph Bondy-Denomy, professor of Microbiology and Immunology at UCSF and senior author of the paper. “We thought anti-CRISPRs just grab Cas proteins to prevent them from cutting, but this was fundamentally different.”
Ribosomes make Cas12 based on genetic instructions stored in the bacteria’s DNA. These instructions get copied onto a molecular blueprint called mRNA. Ribosomes then use the mRNA to assemble Cas12 — one amino acid at a time.
Led by Nicole Marino from UCSF, the scientists, including HIRI Director Jörg Vogel, his PhD student Leandro Buhlmann, and Milan Gerovac, a former Vogel lab postdoc and current leader of the group “Complexes in Phage-infected Cells”, tested each step along the way — from DNA to mRNA to protein — to determine exactly when Cas12 went missing. AcrVA2 neither blocked the Cas12 gene, which would have prevented the Cas12 mRNA from being made, nor destroyed the mRNA in test tubes. So, the scientists looked to see if the anti-CRISPR was doing something to the ribosome.
They found AcrVA2 lying in wait as the ribosome made protein after protein. But as soon as AcrVA2 saw the first few amino acids of Cas12 begin to emerge, it grabbed the growing protein and triggered an assembly line shutdown. “This anti-CRISPR has one hand for holding onto ribosomes, and another that selects just one protein: Cas12,” Bondy-Denomy said. “It forces the ribosome to treat a normal message like a defective one.” Once the ribosome was jammed, the bacteria’s quality control mechanisms destroyed both the budding Cas12 protein and its mRNA blueprint.
The discovery appears to be the first of its kind: one protein interrupting the manufacture of another on ribosomes. It’s just the latest twist in our understanding of the evolutionary race between bacteria and viruses.